← Scoopfeeds — Intelligent news, curated.
Johnson & Johnson (JNJ): Focused on Cancer and Neuroscience as a Top Dividend Aristocrat Stock to Buy
business

Johnson & Johnson (JNJ): Focused on Cancer and Neuroscience as a Top Dividend Aristocrat Stock to Buy

Yahoo Finance · Jul 1, 2026, 7:54 PM · Also reported by 1 other source

Johnson & Johnson (JNJ): Focused on Cancer and Neuroscience as a Top Dividend Aristocrat Stock to Buy

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Gabelli dividend & income trust director Michael Melarkey buys $57,040 in stock

More in business

Investing.com
Europe gas hits 3-week high as low storage worries outshine U.S.-Iran progress
Investing.com
Toronto home sales rise in June for fourth straight month
Investing.com
Bucher downgraded at RBC as weakening farm spending clouds earnings outlook
Investing.com
Powerful Iranian general reappears in public ahead of Khamenei funeral - AP
CoinDesk
Tokenization could make finance faster, but also more susceptible to shocks, IMF says
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop